Medtech’s ROSA Robotic Surgery System to be Featured at the 84th American Association of Neurological Surgeons (AANS) Annual Meeting

MONTPELLIER, France, April 25, 2016 (GLOBE NEWSWIRE) — MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, today announced that it will showcase its ROSA™ robotic surgery systems at the upcoming 84thAmerican Association of Neurological Surgeons (AANS) Annual Meeting, being held April 30 – May 4 in Chicago, IL.

Medtech’s ROSA™ robotic surgery system was developed to assist in a variety of minimally invasive neurological procedures while simultaneously increasing safety and reliability for the surgeon and patient. During the conference, Medtech will demonstrate the ROSA™ system at Booth #5035.

In addition, the ROSA™ robot will be featured at a workshop during the conference. Details of the workshop follow:

Advertisement

Title: 018 Stereotactic and Functional Neurosurgery – Hands-on Workshop
Date: May 1, 2016
Time: 7:30 a.m. – 4:30 p.m.

A ROSA™ robotic surgery system will be highlighted during functional neurosurgery sessions at AANS. The sessions will include discussions highlighting the minimally invasive approach that surgeons are able to utilize through ROSA™. Details of the sessions follow:

Title: Scientific Session III: Stereotactic and Functional
Date: May 2, 2016
Time: 2 p.m. – 5:30 p.m.

Title: AANS/CNS Section on Stereotactic and Functional Surgery
Date: May 3, 2016
Time: 2 p.m. – 5:30 p.m.

About the 2016 AANS Annual Scientific Meeting

Attended by neurosurgeons, neurosurgical residents, medical students, neuroscience nurses, clinical specialists, physician assistants, allied health professionals and other medical professionals, the AANS Annual Scientific Meeting is the largest gathering of neurosurgeons in the nation, with an emphasis on the field’s latest research and technological advances. More than 1,200 scientific abstracts were submitted for the 2015 AANS Annual Scientific Meeting. The scientific presentations accepted for the 2016 event will represent cutting-edge examples of the incredible developments taking place within the field of neurosurgery. Additional information about the 2016 AANS Annual Scientific Meeting and the meeting program can be found here.

About MEDTECH

Founded in 2002 by Bertin NAHUM and based in Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment.

In 2007, MEDTECH developed ROSA™,  an innovative technological device devoted to  brain surgery procedures.  ROSA™ has been approved in Europe,  the United States and Canada.

In 2013 MEDTECH received the “European Company of the Year Award” in the “robotic neurosurgery” category from Frost & Sullivan.

In July 2014, MEDTECH obtained the CE marking for its new product ROSA™ Spine, a robotic- assistive device for minimally invasive surgery of the spine.

In October 2014, MEDTECH won the “Révélation” prize in the Mediterranean Deloitte Technology Fast 50 Awards.

In 2015 MEDTECH received the “2016 Company of the Year Award” in the “robotic neurosurgery” category from Frost & Sullivan.

In November 2015, MEDTECH was honored by Deloitte In Extenso for its excellent performance in the Technology Fast 50 Mediterranean Awards, in the “listed company” category.

In January 2016, MEDTECH obtained the FDA clearance for its new product, ROSA™ Spine, a robotic-assistive device for minimally invasive surgery of the spine.

CONTACT: CONTACT MEDTECH
Christophe Sibillin
Chief Financial Officer
Tel : +33 (0)4 67 10 77 40

INVESTORS
Corinne Puissant
Tel : +33 (0)1 53 67 36 77
cpuissant@actus.fr

PRESS
Alexandra Prisa (EU)          
Tel. : +33(0)1 53 67 36 90 
aprisa@actus.fr                  

Joanna Zimmerman (US)
Tel : +1 646-536-7006
jzimmerman@theruthgroup.com
Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement